Pierre Leblond

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

Cancers

Journal of clinical medicine

International journal of molecular sciences

Neuro-oncology

Centre Oscar Lambret

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Oscar Lambret

France

M.D? Ph.D. :: PEDIATRIC ONCOLOGY

Publications

Clément Berthelot, Paul Huchedé, Adrien Bertrand-Chapel, Pierre-Aurélien Beuriat, Pierre Leblond, Marie Castets
Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old? International journal of molecular sciences 25 (6) (2024)
Clément Berthelot, Paul Huchedé, Adrien Bertrand-Chapel, Pierre-Aurélien Beuriat, Pierre Leblond, Marie Castets
Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old? International journal of molecular sciences 25 (6) (2024)
Clément Berthelot, Paul Huchedé, Adrien Bertrand-Chapel, Pierre-Aurélien Beuriat, Pierre Leblond, Marie Castets
Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old? International journal of molecular sciences 25 (6) (2024)
Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, Nadège Néant, Caroline Solas, Arthur Sterin, Thomas Boulanger, Isabelle Aerts, Cecile Faure Conter, Anne-Isabelle Bertozzi, Pascal Chastagner, Natacha Entz-Werlé, Emilie De Carli, Marie-Cécile Le Deley, Gauthier Bouche, Anne Isabelle Bertozzi
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX). Cancers 15 (7) (2023)
Pierluigi Calò, Nicolas Pianton, Alexandre Basle, Alexandre Vasiljevic, Marc Barritault, Pierre Aurélien Beuriat, Cecile Faure Conter, Pierre Leblond
Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma. Cancers 15 (4) (2023)
Rebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, Valentina Zschernack, Arnault Tauziede Espariat, Francesca R Buttarelli, Felice Giangaspero, Jacques Grill, Christine Haberler, Simon M L Paine, Ian Scott, Thomas S Jacques, Martin Sill, Stefan Pfister, John-Paul Kilday, Pierre Leblond, Maura Massimino, Hendrik Witt, Piergiorgio Modena, Pascale Varlet, Torsten Pietsch, Richard G Grundy, Kristian W Pajtler, Timothy A Ritzmann, null null
Optimising biomarkers for accurate ependymoma diagnosis, prognostication and stratification within International Clinical Trials: A BIOMECA study. Neuro-oncology (2023)
Camille Winnicki, Pierre Leblond, Franck Bourdeaut, Anne Pagnier, Gilles Paluenzela, Pascal Chastagner, Gwenaelle Duhil-De Benaze, Victoria Min, Hélène Sudour-Bonnange, Catherine Piette, Natacha Entz-Werlé, Sylvie Chabaud, Anne Isabelle Bertozzi
Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. Journal of clinical medicine 12 (4) (2023)
Pierluigi Calò, Nicolas Pianton, Alexandre Basle, Alexandre Vasiljevic, Marc Barritault, Pierre Aurélien Beuriat, Cecile Faure Conter, Pierre Leblond
Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma. Cancers 15 (4) (2023)
Camille Winnicki, Pierre Leblond, Franck Bourdeaut, Anne Pagnier, Gilles Paluenzela, Pascal Chastagner, Gwenaelle Duhil-De Benaze, Victoria Min, Hélène Sudour-Bonnange, Catherine Piette, Natacha Entz-Werlé, Sylvie Chabaud, Anne Isabelle Bertozzi
Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. Journal of clinical medicine 12 (4) (2023)
Pierluigi Calò, Nicolas Pianton, Alexandre Basle, Alexandre Vasiljevic, Marc Barritault, Pierre Aurélien Beuriat, Cecile Faure Conter, Pierre Leblond
Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma. Cancers 15 (4) (2023)
Camille Winnicki, Pierre Leblond, Franck Bourdeaut, Anne Pagnier, Gilles Paluenzela, Pascal Chastagner, Gwenaelle Duhil-De Benaze, Victoria Min, Hélène Sudour-Bonnange, Catherine Piette, Natacha Entz-Werlé, Sylvie Chabaud, Anne Isabelle Bertozzi
Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. Journal of clinical medicine 12 (4) (2023)
Camille Winnicki, Pierre Leblond, Franck Bourdeaut, Anne Pagnier, Gilles Paluenzela, Pascal Chastagner, Gwenaelle Duhil-De Benaze, Victoria Min, Hélène Sudour-Bonnange, Catherine Piette, Natacha Entz-Werlé, Sylvie Chabaud, Anne Isabelle Bertozzi
Retrospective National "Real Life" Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol. Journal of clinical medicine 12 (4) (2023)
Irene Slavc, Lisa Mayr, Natalia Stepien, Johannes Gojo, Maria Aliotti Lippolis, Amedeo A Azizi, Monika Chocholous, Alicia Baumgartner, Cora S Hedrich, Stefan Holm, Astrid Sehested, Pierre Leblond, Karin Dieckmann, Christine Haberler, Thomas Czech, Marcel Kool, Andreas Peyrl
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic Approach. Cancers 14 (20) (2022)
Coline Puvilland, Carine Villanueva, Anaëlle Hemmendinger, Laure Kornreich, Iva Gueorguieva, Mélodie-Anne Karnoub, Pierre Aurélien Beuriat, Pierre Leblond
Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature. Cancers 15 (1) (2022)
Coline Puvilland, Carine Villanueva, Anaëlle Hemmendinger, Laure Kornreich, Iva Gueorguieva, Mélodie-Anne Karnoub, Pierre Aurélien Beuriat, Pierre Leblond
Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature. Cancers 15 (1) (2022)
Coline Puvilland, Carine Villanueva, Anaëlle Hemmendinger, Laure Kornreich, Iva Gueorguieva, Mélodie-Anne Karnoub, Pierre Aurélien Beuriat, Pierre Leblond
Growth Hormone Replacement Therapy Seems to Be Safe in Children with Low-Grade Midline Glioma: A Series of 124 Cases with Review of the Literature. Cancers 15 (1) (2022)
Christelle Dufour, Stephanie Foulon, Anne Geoffray, Julien Masliah-Planchon, Dominique Figarella-Branger, Valerie Bernier-Chastagner, Laetitia Padovani, Léa Guerrini-Rousseau, Cecile Faure-Conter, Celine Icher, Anne-Isabelle Bertozzi, Pierre Leblond, Tasnime Akbaraly, Franck Bourdeaut, Nicolas André, Celine Chappé, Pascale Schneider, Emilie De Carli, Pascal Chastagner, Claire Berger, Julien Lejeune, Christine Soler, Natacha Entz-Werlé, Marie-Bernadette Delisle
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5. Neuro-oncology 23 (7) (2021)
Pierre-Aurélien Beuriat, Irene Cristofori, Nathalie Richard, Lara Bardi, Celia Loriette, Alexandru Szathmari, Federico Di Rocco, Pierre Leblond, Didier Frappaz, Cécile Faure-Conter, Line Claude, Carmine Mottolese, Michel Desmurget
Cerebellar lesions at a young age predict poorer long-term functional recovery. Brain communications 2 (1) (2020)
Stephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, Emilie De Carli, Anne-Isabelle Bertozzi, Anne Pagnier, Fanny Fouyssac, Karsten Nysom, Isabelle Aerts, Pierre Leblond, Frederic Millot, Claire Berger, Sandra Canale, Angelo Paci, Vianney Poinsignon, Aurelie Chevance, Monia Ezzalfani, Dominique Vidaud, Angela Di Giannatale, Raquel Hladun-Alvaro, Francois M Petit, Gilles Vassal, Birgit Geoerger, Marie-Cécile Le Deley, Jacques Grill
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma. Neuro-oncology advances 2 (1) (2020)

Pierre Leblond.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pierre Leblond